Clinical Trials for Recurrent Plasma Cell Myeloma

Find clinical trials for recurrent plasma cell myeloma. Discover research opportunities and treatment options in your area.

8 Active Trials Found

Showing 8 trials on this page

Page 1 of 1

Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma

NCT ID: NCT05363111

This clinical trial is investigating a new treatment approach for patients with relapsed or refractory multiple myeloma, a type of blood cancer. The study is looking at a combination of three thera...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma

NCT ID: NCT03710421

This clinical trial is exploring a new treatment called CS1-CAR T therapy for patients with a type of blood cancer known as multiple myeloma, specifically for those whose disease has returned or ha...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma

NCT ID: NCT04640779

This clinical trial is studying a combination of two medications, low-dose selinexor and choline salicylate, to find out their safety and the best dose to use for treating patients with certain typ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States

Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma

NCT ID: NCT05391750

This clinical trial is exploring the combination of two drugs, venetoclax and tocilizumab, to treat patients with a specific type of multiple myeloma, which is a kind of blood cancer. The trial aim...

Recruiting

Phase: PHASE1 Type: interventional Locations: Atlanta, Georgia, United States

A Vaccine (VSV-hIFNβ-NIS) with or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

NCT ID: NCT03017820

This clinical trial is exploring a new treatment option for patients with certain types of blood cancers, including relapsed or hard-to-treat multiple myeloma, acute myeloid leukemia (AML), and var...

Recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, Jacksonville, Florida, United States +1 more

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

NCT ID: NCT05312255

This clinical trial is exploring new ways to help patients with multiple myeloma, a type of blood cancer, improve their quality of life and boost their immune system without using chemotherapy. The...

Recruiting

Phase: NA Type: interventional Locations: Buffalo, New York, United States

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

NCT ID: NCT04508790

This clinical trial is looking at a new treatment combination for patients with multiple myeloma, a type of blood cancer that can come back after treatment or does not respond to existing therapies...

Recruiting

Phase: PHASE2 Type: interventional Locations: Duarte, California, United States

Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial

NCT ID: NCT05514990

The AMBUSH trial is studying a combination of treatments for people with multiple myeloma, a type of blood cancer that comes back after treatment or does not respond to it. The trial is testing whe...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States, Los Angeles, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions